Pulmonary hypertension: pathophysiology as a basis for clinical decision making (Q33794815)

29 July 2017

1 reference

title

Pulmonary hypertension: pathophysiology as a basis for clinical decision making (English)

1 reference

29 July 2017

1 reference

1 reference

pulmonary hypertension

1 reference

Rabinovitch M

1

1 reference

29 July 2017

publication date

1 November 1999

1 reference

The Journal of Heart and Lung Transplantation

29 July 2017

published in

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

11

1 reference

29 July 2017

page(s)

1041-1053

1 reference

Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

The Spectrum of Pulmonary Vascular Disease in Transposition of the Great Arteries

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Pulmonary vascular disease in complete transposition of the great arteries: a study of 200 patients.

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Transposition of the great arteries with intact ventricular septum and patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

The development of pulmonary vascular obstructive disease after successful Mustard operation in early infancy

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Pulmonary vascular disease in complete atrioventricular canal defect

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Quantitative analysis of the pulmonary wedge angiogram in congenital heart defects. Correlation with hemodynamic data and morphometric findings in lung biopsy tissue

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Lung biopsy with frozen section as a diagnostic aid in patients with congenital heart defects.

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Pulmonary vascular structure in patients dying after a Fontan procedure. The lung as a risk factor

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Effect of ambient oxygen changes on platelet activating factor production by fetal ovine endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

A study of nerves containing peptides in the pulmonary vasculature of healthy infants and children and of those with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Oxygen sensing in airway chemoreceptors

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Increased respiratory system resistance and bronchial smooth muscle hypertrophy in children with acute postoperative pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Circulating endothelin in children with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Plasma endothelin levels and surgically correctable pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Regulation of Tenascin-C, a Vascular Smooth Muscle Cell Survival Factor that Interacts with the αvβ3 Integrin to Promote Epidermal Growth Factor Receptor Phosphorylation and Growth

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Hemodynamic consequences of inotropic support with digoxin or amrinone in lambs with ventricular septal defect.

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Endothelinb receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Chronic pulmonary hypertension in sheep: temporal progression of lesions

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Pulmonary hypertension and arterial changes in calves with a systemic-to-left pulmonary artery connection

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Serum-induced vascular smooth muscle cell elastolytic activity through tyrosine kinase intracellular signalling

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Endothelial and serum factors which include apolipoprotein A1 tether elastin to smooth muscle cells inducing serine elastase activity via tyrosine kinase-mediated transcription and translation

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Regulation of astrocytic tenascin by basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Functional interplay between interleukin-1 receptor and elastin binding protein regulates fibronectin production in coronary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Lymphocyte transendothelial migration toward smooth muscle cells in interleukin‐1 β‐stimulated co‐cultures is related to fibronectin interactions with α4β1 and α5β1 integrins

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Microtubule-associated protein 1 light chain 3 is a fibronectin mRNA-binding protein linked to mRNA translation in lamb vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Vascular endothelial growth factor in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32

1 reference

https://api.crossref.org/works/10.1016/S1053-2498(99)50015-7

7 January 2021

10.1016/S1053-2498(99)00015-7

Identifiers

DOI

1 reference

29 July 2017

1 reference